Name: Nerve Disease ALS and Gradual Loss of Muscle Function: Amyotrophic Lateral Sclerosis (en Inglés)
Price: 49330.00 CLP
Availability: InStock
Author: Miller, Mary E.
ISBN: 9781944749798

portada Nerve Disease ALS and Gradual Loss of Muscle Function: Amyotrophic Lateral Sclerosis (en Inglés)

Nerve Disease ALS and Gradual Loss of Muscle Function: Amyotrophic Lateral Sclerosis (en Inglés)

Formato

Libro Físico

Autor

Mary E. Miller

Editorial

Momentum Press

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.09 kg.

ISBN13

9781944749798

Categorías

Neurología y neurofisiología clínicas
Genética (no médica)

Nerve Disease ALS and Gradual Loss of Muscle Function: Amyotrophic Lateral Sclerosis (en Inglés)

Mary E. Miller (Autor) · Momentum Press · Tapa Blanda

Libro Nuevo Importado

Envío: 16 a 21 días háb.

$ 98.660$ 49.330

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 49.330

Llega entre el 04 Ago y el 11 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Nerve Disease ALS and Gradual Loss of Muscle Function: Amyotrophic Lateral Sclerosis (en Inglés)"

Amyotrophic lateral sclerosis, ALS, is a common form of motor neuron disease that involves a loss of function in upper and lower motor neurons. ALS causes a progressive loss of muscle function that frequently initiates in the limbs, called limb-onset ALS, or initiates in facial muscles, called bulbar-onset ALS. This book describes the current understanding of ALS symptoms, diagnosis, causes, and treatments. Initial symptoms vary in type of muscle dysfunction, intensity of symptoms, and speed of disease progression. Diagnosis requires loss of function in both upper and lower motor neurons for limb- and bulbar-onset ALS, distinguishing ALS from other neuromuscular diseases. Although no cause or initial trigger has been determined for ALS, eventually both limb and bulbar muscles will show dysfunction as the disease progresses. In later stages of the disease, muscle dysfunction typically leads to respiratory failure and death. Management of neurotransmitter levels in patients can prolong life by months, but no cure exits for the disease. Other treatments exist that can help patients manage muscle weakness or spasms as the disease progresses. The book concludes by considering future detection, treatment, and diagnostic approaches with the goal of preventing disease initiation or progression.